{
  "thread": {
    "uuid": "7a67911ece3675a3c7817c2d7b24471bbfaf59f2",
    "url": "https://stock.stockstar.com/IG2026011500017503.shtml",
    "site_full": "stock.stockstar.com",
    "site": "stockstar.com",
    "site_section": "http://stock.stockstar.com/list/5257.shtml",
    "site_categories": [
      "science and technology",
      "economy, business and finance"
    ],
    "section_title": "新三板公司-股票频道-证券之星-聚焦优质投资",
    "site_title": null,
    "title": "维琪科技北交所IPO：国信证券保代楼瑜保荐上市企业近两年利润下滑75%，保代郑桂斌无保荐经验_股票频道_证券之星",
    "title_full": "维琪科技北交所IPO：国信证券保代楼瑜保荐上市企业近两年利润下滑75%，保代郑桂斌无保荐经验_股票频道_证券之星",
    "published": "2026-01-15T05:27:00.000+02:00",
    "replies_count": 0,
    "participants_count": 0,
    "site_type": "news",
    "country": "CN",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 41351,
    "domain_rank_updated": "2026-01-11T23:00:00.000+02:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "7a67911ece3675a3c7817c2d7b24471bbfaf59f2",
  "url": "https://stock.stockstar.com/IG2026011500017503.shtml",
  "ord_in_thread": 0,
  "author": null,
  "published": "2026-01-15T05:27:00.000+02:00",
  "title": "维琪科技北交所IPO：国信证券保代楼瑜保荐上市企业近两年利润下滑75%，保代郑桂斌无保荐经验_股票频道_证券之星",
  "text": "（原标题：维琪科技北交所IPO：国信证券保代楼瑜保荐上市企业近两年利润下滑75%，保代郑桂斌无保荐经验）\n挖贝网1月15日消息，维琪科技（874747）正排队北交所IPO，去年11月收到二轮问询。公司计划公开发行募资3.66亿元，保荐机构为国信证券，保荐代表人为楼瑜、郑桂斌。\n按照保荐承销费率8%估算，国信证券保荐承销费约可达2928万元。\n从维琪科技两名保代过去保荐项目经验看，结合中国证券业协会官网信息，楼瑜自2012年获注册为保代后，保荐项目经验丰富，共保荐10个项目，其中2个是首发项目。\n楼瑜保荐募资规模最大的首发项目是贝泰妮，该公司2021年3月在创业板上市，2022年扣非后净利润增长至9.51亿历史最高水平后，2023年下滑35.02%，2024年再下滑61.12%至2.4亿元，两年累计下滑75%。贝泰妮IPO发行价为47.33元，1月14日收盘价（后复权）为44.29元，处于破发状态。\n（楼瑜保荐项目贝泰妮上市以来业绩表现）\n楼瑜保荐中润光学于2023年2月在科创板上市，上市当年2023年净利润下滑11.64%，不过紧接着2024年净利润上涨47.06%至5342.98万元。\n另一名保代郑桂斌过去保荐项目数量为0，无首发、非公开发行等项目的保荐经验。\n挖贝研究院资料显示，维琪科技处于化妆品原料研发及产业化领域，已建立以皮肤活性多肽为主、以中国特色植物原料和油脂、乳化剂等基础原料为补充的化妆品原料体系，同时为客户提供原料定制开发和化妆品成品设计和制造等产品或服务，具备从原料创新研发、定制开发和生产应用到成品制造的全链条交付能力。前五名客户包括丸美生物、深圳羽素、广州蜚美等。\n维琪科技2024年营收为2.48亿元，归母净利润为7064万元。",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "chinese",
  "sentiment": "negative",
  "categories": [
    "Economy, Business and Finance"
  ],
  "topics": [
    "Economy, Business and Finance->business financing",
    "Economy, Business and Finance->business reporting and performance",
    "Economy, Business and Finance->corporate news and profiles"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": null,
  "webz_reporter": false,
  "external_links": [],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": null,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2026-01-15T07:50:10.177+02:00",
  "updated": "2026-01-15T07:52:22.000+02:00"
}